sulfasalazine has been researched along with Spondylarthropathies in 11 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Spondylarthropathies: Heterogeneous group of arthritic diseases sharing clinical and radiologic features. They are associated with the HLA-B27 ANTIGEN and some with a triggering infection. Most involve the axial joints in the SPINE, particularly the SACROILIAC JOINT, but can also involve asymmetric peripheral joints. Subsets include ANKYLOSING SPONDYLITIS; REACTIVE ARTHRITIS; PSORIATIC ARTHRITIS; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy and tolerability of single-agent sulfasalazine (SSZ) with combination therapies composed of SSZ and methotrexate (MTX) and SSZ, MTX and hydroxychloroquine (HCQ) in active spondyloarthropathy (SpA) patients with peripheral arthritis." | 5.11 | Combination therapies in spondyloarthropathies. ( Apraş, S; Calgüneri, M; Cobankara, V; Ertenli, I; Kiraz, S; Oztürk, MA, 2004) |
| "A young woman thought to have seronegative rheumatoid arthritis developed Stevens-Johnson syndrome after treatment with sulfasalazine; this resolved with prednisone." | 3.79 | Giant cell myocarditis in a patient with a spondyloarthropathy after a drug hypersensitivity reaction. ( Cooper, LT; Davies, RA; Grenon, J; Mesana, TG; Mielniczuk, LM; Mitoff, PR; Veinot, JP, 2013) |
| "Uveitis is a prevalent disease that mainly affects young people." | 2.43 | Uveitis. ( Martín-Mola, E; Muñoz-Fernández, S, 2006) |
| "We diagnosed late onset spondyloarthropathy according to clinic and radiographic findings." | 1.38 | Late onset spondyloarthropathy mimicking polymyalgia rheumatica. ( Altındağ, O; Aydeniz, A; Gürsoy, S; Oğüt, E, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Marino, A | 1 |
| De Souza, M | 1 |
| Giani, T | 1 |
| Cimaz, R | 1 |
| Rudwaleit, M | 1 |
| Walscheid, K | 1 |
| Heiligenhaus, A | 1 |
| Mitoff, PR | 1 |
| Mesana, TG | 1 |
| Mielniczuk, LM | 1 |
| Grenon, J | 1 |
| Veinot, JP | 1 |
| Cooper, LT | 1 |
| Davies, RA | 1 |
| MacMullan, PA | 1 |
| Madigan, AM | 1 |
| Paul, N | 1 |
| Peace, AJ | 1 |
| Alagha, A | 1 |
| Nolan, KB | 1 |
| McCarthy, GM | 1 |
| Kenny, D | 1 |
| Silva-Fernández, L | 1 |
| Pérez-Vicente, S | 1 |
| Martín-Martínez, MA | 1 |
| López-González, R | 1 |
| Aydeniz, A | 1 |
| Altındağ, O | 1 |
| Oğüt, E | 1 |
| Gürsoy, S | 1 |
| Kiratiseavee, S | 1 |
| Brent, LH | 1 |
| Calgüneri, M | 1 |
| Cobankara, V | 1 |
| Oztürk, MA | 1 |
| Ertenli, I | 1 |
| Kiraz, S | 1 |
| Apraş, S | 1 |
| Muñoz-Fernández, S | 1 |
| Martín-Mola, E | 1 |
| Scherer, HU | 1 |
| Burmester, GR | 1 |
| Stone, M | 1 |
| Inman, RD | 1 |
6 reviews available for sulfasalazine and Spondylarthropathies
| Article | Year |
|---|---|
Pharmacotherapy for juvenile spondyloarthritis: an overview of the available therapies.
Topics: Adult; Antirheumatic Agents; Arthritis, Juvenile; Child; Clinical Trials as Topic; Humans; Methotrex | 2020 |
[Uveitis in spondyloarthritis].
Topics: Administration, Topical; Adrenal Cortex Hormones; Antirheumatic Agents; HLA-B27 Antigen; Humans; Int | 2017 |
Spondyloarthropathies: using presentation to make the diagnosis.
Topics: Antirheumatic Agents; Back Pain; Blood Sedimentation; C-Reactive Protein; Diagnosis, Differential; H | 2004 |
Uveitis.
Topics: Animals; Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Disease | 2006 |
[Biologicals in the treatment of rheumatic diseases].
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monocl | 2006 |
Recent developments in the therapy of spondyloarthropathies.
Topics: Alleles; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal; Antirheumati | 2000 |
1 trial available for sulfasalazine and Spondylarthropathies
| Article | Year |
|---|---|
Combination therapies in spondyloarthropathies.
Topics: Adult; Arthritis; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; | 2004 |
4 other studies available for sulfasalazine and Spondylarthropathies
| Article | Year |
|---|---|
Giant cell myocarditis in a patient with a spondyloarthropathy after a drug hypersensitivity reaction.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Drug Hypersensitivity; Echocardiography; | 2013 |
Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Platelets; Cohort Studies; Female; Humans; | 2016 |
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cohort Studies; Cyclophosphamide; Cyclospo | 2015 |
Late onset spondyloarthropathy mimicking polymyalgia rheumatica.
Topics: Age of Onset; Anti-Inflammatory Agents; Biomarkers; Blood Sedimentation; C-Reactive Protein; Diagnos | 2012 |